I've watched the same disaster movie play out at company after company for over a decade. The plot never changes. A pharma or biotech manufacturer discovers during an FDA audit that their training program is fundamentally broken. Operators who can't explain why they do what they do. SOPs that read like they were written by committee in a fever dream. Training records that show 100% completion rates but zero actual competency.
Everyone acts surprised, but they shouldn't be. The signs were there all along. We just got really good at ignoring them.
But don't take my word for it. The FDA's own inspection data tells the story in black and white, and the numbers are getting worse, not better.
The Evidence: What FDA Is Actually Finding
The following findings are drawn from FDA Form 483 inspectional observations and 85+ warning letters issued in 2025. These aren't hypotheticals. These are the exact deficiencies FDA investigators are citing, and the exact gaps that training systems are supposed to prevent.
Source: FDA Inspectional Observation Data and analysis of FY 2025 warning letter trends.
Training Deficiencies
Employees engaged in manufacturing, processing, packing, or holding drug products lack the education, training, and experience to perform their assigned functions.
Firms fail to provide continuing training in cGMP requirements, including updates when procedures change.
Personnel are not trained on relevant SOPs before performing tasks, leading to procedural deviations and product quality failures.
Failure to document training completion, competency assessments, or qualification of employees. This is a consistent top-10 Form 483 finding.
Training exists on paper but lacks practical assessments to verify that employees can actually perform tasks correctly.
87% of 2025 warning letters recommended engagement of a qualified GMP consultant, reflecting firms' inability to self-remediate, often rooted in insufficient internal training capability.
Compliance Failures
The quality unit does not have the authority, independence, or resources to exercise its responsibilities. This was cited 54 times across 85 warning letters in 2025.
Written procedures for production and process control are not established or followed. This was cited 33 times in 2025 warning letters and is consistently a top-3 Form 483 observation.
Firms fail to thoroughly investigate unexplained discrepancies, OOS results, or batch failures before releasing product. Observations in this category saw a 171% increase in FY 2024.
Corrective and preventive actions lack root cause analysis, measurable milestones, or effectiveness verification. CAPAs are closed without confirming the fix worked.
Failure to perform identity testing or conformity testing of incoming components. This is the #1 most cited violation in 2025, appearing in 49 of 85 warning letters.
Firms fail to remediate prior Form 483 findings, leading to escalation to warning letters. FDA increasingly references inadequate 483 responses in enforcement correspondence.
Documentation Deficiencies
Missing signatures, data gaps, unrecorded manufacturing steps, or incomplete production records.
Absent or unenforced audit trails, unauthorized data alterations, backdated entries, and lack of electronic record controls. 15% of 2025 warning letters cited data integrity concerns.
QA releases batches without completing review of all test results and batch documentation.
Deviations from written production and process control procedures are not documented, investigated, or justified.
Laboratory and production activities are not documented at the time they are performed. Instead, entries are made after the fact or reconstructed.
Lab records do not include complete data from all tests, calculations, or analyst identification to assure compliance with specifications.
Technical / Operational Performance
Failure to generate adequate data to evaluate manufacturing variability or demonstrate process control across lifecycle stages (PV Stages 1, 2, and 3). This category saw a 133% increase in FY 2024 observations.
Products are released without appropriate laboratory determinations confirming conformance to final specifications. This was cited 26 times in 2025 warning letters.
Equipment and utensils not cleaned, maintained, or sanitized at appropriate intervals to prevent contamination.
Facility design inadequate for aseptic operations, including deficient environmental monitoring programs and cleanroom controls.
Inadequate controls for microbiological contamination, including lack of media fills, environmental monitoring trending, and sterilization validation.
Failure to establish or follow an adequate stability testing program. This was cited in 17% of all FY 2024 Form 483s.
Specifications, standards, sampling plans, and test procedures are not scientifically sound or appropriately established.
Your training system is the first line of defense against every finding on this list. Without qualified personnel who understand procedures, documentation requirements, and technical operations, compliance gaps become systemic, and systemic gaps become warning letters.
GxP Frame provides the battle-tested training frameworks that close these gaps before inspectors find them.
That's the landscape. Now let's talk about why it looks this way, and what's actually driving these failures from the inside.
The Root of the Problem: We Built This House on Sand
Understaffed and Under-Resourced from Day One
Here's a fun exercise. Walk into any pharma company and ask how many people are in their training department. Now ask how many manufacturing operators they have. I guarantee the ratio will make you wince.
I've seen 200-person manufacturing sites with exactly one training specialist. That person is somehow expected to develop curricula, manage LMS systems, conduct competency assessments, maintain training records, and still have time to actually train people. It's like asking one person to be the entire fire department for a major city.
But here's the kicker. When budget cuts come, and they always come, training is the first department to get the axe. Because training doesn't make product, right? It just makes the people who make the product competent. Totally optional.
The Copy-Paste Culture That's Killing Us
Walk into most training departments and you'll find filing cabinets full of training materials "borrowed" from other companies. Sometimes they don't even bother to change the logos. I once sat through a training session for a cell therapy company that was teaching operators how to make small molecule tablets. Nobody questioned it because hey, training is training, right?
This copy-paste culture creates a dangerous illusion of compliance. Companies think they have robust training programs because they have thick binders full of materials. But those materials have about as much relevance to their actual processes as a cookbook from Mars.
Startups: All the Risks, None of the Infrastructure
Startups face an impossible choice. Move fast and break things, or build proper infrastructure from the ground up. Guess which one wins when investors are breathing down your neck and you need to hit clinical milestones.
So they hire brilliant scientists and engineers, throw them into manufacturing roles, and assume they'll figure it out. No training infrastructure, no documented processes, no institutional knowledge. Just smart people making it up as they go along. It works until it doesn't. And when it doesn't, the FDA audit findings read like a horror novel.
The Detection Problem: By the Time You See the Smoke, the House Is Already Burning
The Lag Between Cause and Effect
Here's what makes training failures so insidious. The gap between a training deficiency and its visible manifestation can be months or even years. An operator might complete training with a fundamental misunderstanding of a critical process step. They'll perform that step incorrectly hundreds of times before anyone notices the pattern. By then, you're not dealing with a training problem. You're dealing with a contamination event, a recall, or worse.
The root cause analysis will eventually trace back to inadequate training, but the damage is done.
Gaming the Numbers Game
Training completion rates are the feel-good metric that tells you absolutely nothing about competency. I've seen companies proudly report 98% training completion rates while their deviation rates skyrocket. It's like measuring the success of a driving school by how many people showed up to watch the videos, regardless of whether they can actually parallel park or know what a stop sign means.
"Read and understand" training is particularly egregious. We hand operators a 47-page SOP written in regulatory-speak, have them click "I understand," and somehow convince ourselves they're now competent to perform complex manufacturing operations. It's bureaucratic theater at its finest.
Last in Line for Everything
When IT gets new systems, manufacturing gets new equipment, and facilities get upgrades, training departments are still using the same creaky LMS from 2003 and wondering why nobody takes them seriously.
This under-investment becomes a vicious cycle. Training systems don't work well, so training effectiveness suffers, so leadership loses confidence in training, so training gets even fewer resources. Meanwhile, the problems compound until they explode during an audit.
How Mediocrity Becomes Permanent
Institutional Inertia Is Real
"We've always done it this way" might be the most dangerous phrase in pharmaceutical manufacturing. It's the corporate equivalent of "hold my beer." Nothing good ever follows.
I've watched companies cling to training approaches that were questionable when they were implemented 15 years ago and are completely obsolete today. But changing means admitting the current system is broken, and nobody wants to be the person who points out the emperor has no clothes.
The Criticism Trap
Here's a psychological barrier nobody talks about. Suggesting improvements to the training program implies criticism of everyone who built and maintained the current system. And some of those people are still in the room, possibly in leadership roles.
So instead of honest conversations about what's broken, we get incremental tweaks and gentle improvements that maintain the illusion of progress while fundamentally changing nothing.
Visibility Only During Disasters
Training problems hide until they can't. Unlike manufacturing equipment that breaks down visibly, or quality systems that generate obvious red flags, training deficiencies lurk in the background until they contribute to a spectacular failure. By then, everyone goes into crisis mode, implements quick fixes, and promises to do better. But once the immediate fire is out, attention drifts elsewhere, and we slowly slide back to mediocrity.
The Skills Mismatch Nobody Wants to Admit
Technical Experts ≠ Technical Writers
Here's a radical idea. The person who understands how to run a bioreactor isn't automatically qualified to write procedure documents. I know, shocking.
Yet we consistently expect manufacturing operators, people hired for their technical skills and attention to detail, to author SOPs like seasoned technical writers. Then we act surprised when the resulting documents are unclear, inconsistent, or downright incomprehensible. It's like expecting a master chef to also be a restaurant critic, food photographer, and cookbook editor. Different skills. Different mindsets. Different training.
The Resentment Factor
Nothing kills engagement faster than asking people to do jobs they're not equipped for. When we force technically competent operators to struggle through document authoring tasks, we create two problems. Resentment toward the training process and objectively terrible documents.
I've seen brilliant cell therapy operators, people who can troubleshoot complex manufacturing issues on the fly, reduced to frustrated, disengaged employees because they're being measured against document authoring standards that have nothing to do with their actual job performance.
Solutions That Actually Work (No Consultants Required)
Role-Based Training Architecture
Stop treating all training like it's one-size-fits-all. An operator needs different knowledge than a QA reviewer, who needs different knowledge than a manufacturing supervisor. Build your training architecture around roles and responsibilities, not arbitrary categories.
Create clear competency maps for each role. What does an operator actually need to know to do their job safely and effectively? Not what might be nice to know someday, but what they need today. Build training around that.
Separate Knowledge Capture from Document Authoring
Here's a practical approach. Have technical experts capture their knowledge through structured interviews, recordings, or demonstrations. Then have actual writers turn that knowledge into clear, usable documents.
This isn't rocket science. News organizations don't expect expert sources to write their own articles. We interview them, extract the key information, and present it clearly. Training departments should work the same way.
Competency-Based Assessment (That Actually Assesses Competency)
Replace "read and understand" training with practical demonstrations and scenario-based assessments. If someone needs to know how to respond to a contamination alarm, test their response to a simulated contamination alarm.
Build assessment criteria around observable behaviors and measurable outcomes. Can they perform the task correctly? Can they explain why they're doing it? Can they identify when something goes wrong? Those are the questions that matter.
Invest in Infrastructure Early
For startups and new facilities, build training infrastructure before you need it. Develop standard approaches for knowledge capture, document creation, and competency assessment while you still have time to think clearly. It's like buying insurance. You hope you never need it, but when you do, you're grateful it's there.
The alternative is frantically trying to build training systems while managing manufacturing operations, clinical timelines, and regulatory submissions simultaneously.
The Bottom Line
Your training program is either a strategic advantage or a liability waiting to happen. There's no middle ground in pharmaceutical manufacturing.
The companies that treat training as a critical business function, that invest in proper infrastructure, hire competent people, and build systems around actual competency rather than compliance theater, they're the ones that survive audits, avoid recalls, and build sustainable manufacturing operations.
The companies that treat training as a necessary evil, a checkbox to be ticked, a cost to be minimized? They make great cautionary tales.
Which one do you want to be?